Driving Productivity in Biotech Clinical Trials Podcast, Series #3

In this series, we discuss how to drive productivity in biotech clinical trials and how to maximize valuation for minimal investment. Historically, R&D productivity has always been an area of focus and priority for the industry, but recent trends are particularly challenging. How do you realize this ultimate goal as protocols are becoming increasingly complex?

Episode 1: Driving Productivity in Biotech Clinical Trials: How to Maximize Valuation for Minimal Cost

Topics:

In this episode, “How to Maximize Valuation for Minimal Cost,” we explore a critical question: Are you focused on regulatory approval, or on maximizing value? Your answer could determine the path your clinical trial takes, and the outcome it delivers.

Participants:

• Host: Dr. Ken Park, VP of R&D Strategy and Innovation Consulting for Fortrea
• Tracy Newbold, VP of Clinical Operations at Lexicon Pharmaceuticals
• Terry Athreya, SVP and Global Head of Clinical Operations for Fortrea
• Alaric Jackson, Chief Technology and Data Officer at Fortrea